Interlekin-mediated tumor suppression: IL-1β suppresses the expression of a negative regulator of p53 HDM2 via up regulation of its target gene, 24/September/2014, 06.48 am

Therapeutic insights into he treatment of stroke, multiple sclerosis, and Alzheimer’s disease: Argonaute-2 promotes neuroprotection via up regulation of its target gene, 24/September/2014, 6.31 am
September 24, 2014
Mechanism of tumorigenesis: MIRNA-125 increases the expression of oncogenic Aurora B via up regulation of its target gene, 24/September/2014, 07.38 am
September 24, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan,  Interlekin-mediated tumor suppression:  IL-1β suppresses  the expression of a negative regulator of p53 HDM2 via up regulation of its target gene, 24/September/2014, 06.48 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that IL-1β, by increasing the expression of its target gene, it may decrease  HDM2. Thereby, it may function as a tumor suppressor. Thus, pharmacological formulations encompassing IL-1β or its activator” may be used to inhibit tumor progression

* Research cooperation

Comments are closed.